U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07449000) titled 'Losartan for Corneal Fibrosis' on Feb. 13.
Brief Summary: This is a prospective, randomized, double-blinded, controlled clinical trial designed to evaluate the efficacy and safety of topical losartan in improving visual acuity, contrast sensitivity and reducing corneal densitometry, corneal aberrations and corneal scarring severity in adult patients with corneal scars of different etiologies. Participants will be randomly assigned to receive either topical losartan 0.8 mg/mL or placebo eyedrops 6 times per day for six months.
Study Start Date: Feb. 12
Study Type: INTERVENTIONAL
Condition:
Corneal Scarring Fibrosis
Intervention:...